Steward Partners Investment Advisory’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33K | Sell |
1,812
-938
| -34% | -$17.1K | ﹤0.01% | 2678 |
|
|
2025
Q1 | $54.6K | Buy |
2,750
+488
| +22% | +$9.68K | ﹤0.01% | 2340 |
|
|
2024
Q4 | $38.8K | Sell |
2,262
-9,166
| -80% | -$157K | ﹤0.01% | 2468 |
|
|
2024
Q3 | $228K | Buy |
11,428
+10,428
| +1,043% | +$208K | ﹤0.01% | 1465 |
|
|
2024
Q2 | $11.2K | Hold |
1,000
| – | – | ﹤0.01% | 2770 |
|
|
2024
Q1 | $6.6K | Hold |
1,000
| – | – | ﹤0.01% | 2959 |
|
|
2023
Q4 | $4.52K | Hold |
1,000
| – | – | ﹤0.01% | 2999 |
|
|
2023
Q3 | $3.58K | Hold |
1,000
| – | – | ﹤0.01% | 2930 |
|
|
2023
Q2 | $3.69K | Hold |
1,000
| – | – | ﹤0.01% | 2888 |
|
|
2023
Q1 | $3.31K | Hold |
1,000
| – | – | ﹤0.01% | 2912 |
|
|
2022
Q4 | $3.88K | Hold |
1,000
| – | – | ﹤0.01% | 2857 |
|
|
2022
Q3 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 2995 |
|
|
2022
Q2 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 2972 |
|
|
2022
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 3064 |
|
|
2021
Q4 | $1K | Sell |
1,000
-3,000
| -75% | -$3K | ﹤0.01% | 3066 |
|
|
2021
Q3 | $5K | Hold |
4,000
| – | – | ﹤0.01% | 2789 |
|
|
2021
Q2 | $6K | Hold |
4,000
| – | – | ﹤0.01% | 6421 |
|
|
2021
Q1 | $7.04K | Hold |
4,000
| – | – | ﹤0.01% | 2916 |
|
|
2020
Q4 | $8K | Hold |
4,000
| – | – | ﹤0.01% | 2367 |
|
|
2020
Q3 | $10K | Buy |
4,000
+3,000
| +300% | +$7.5K | ﹤0.01% | 2125 |
|
|
2020
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 2363 |
|
|
2020
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 2258 |
|
|
2019
Q4 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 2276 |
|
|
2019
Q3 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 2277 |
|
|
2019
Q2 | $3K | Buy |
+1,000
| New | +$3K | ﹤0.01% | 2326 |
|